Clinical Trial Update: Safety, PK and Efficacy Study of SJP-0132 in Subjects With Dry Eye Disease [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial updates on SJP-0132 in dry eye disease show completed Phase 1/2 study with safety, pharmacokinetics, and efficacy data posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Disease
• Dry Eye Syndrome

Drugs mentioned

• SJP-0132

Snippet

Sponsor: Senju Pharmaceutical Co., Ltd. | Conditions: Dry Eye Disease, Dry Eye Syndrome | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-04-20